The Yusho poisoning incident, caused by rice oil contaminated with polychlorinated biphenyls (PCBs), polychlorinated quarterphenyls (PCQs), and polychlorinated dibenzofurans (PCDFs) generated by heat-denatured PCBs, occurred in 1968 in western Japan. Although severe symptoms are rarely observed today, the levels of PCBs and PCDFs in the sera of Yusho patients remain high. The aryl hydrocarbon receptor (AhR), which also acts as a dioxin receptor, is a transcriptional regulator that mediates dioxin toxicity. Recent studies show that dioxin mediates its immune toxic effects via AhR and that AhR activation induces dysregulation of interleukin (IL)-17- producing T (TH17) cells. This study therefore hypothesized that Yusho patients would show dysregulated TH17 cell-mediated immune responses. To validate the hypothesis, levels of IL-17 and IL-22, each secreted by TH17 cells, along with IL-1β and IL-23 were measured in serum samples from 40 Yusho patients and 40 age-matched controls. Levels of tumor necrosis factor (TNF)-α potentially secreted by TH17 cell-stimulated neutrophils and macrophages were also measured. The results indicated that serum IL-17 levels, as well as those of IL-1β, IL-23, and TNFα, were significantly higher in Yusho patients than in controls. In contrast, serum IL-22 levels were significantly lower in the Yusho patients. These results suggest that Yusho patients have dysregulated TH17 cell-mediated immune responses that may be linked to inflammation.

Download full-text PDF

Source
http://dx.doi.org/10.3109/1547691X.2013.835890DOI Listing

Publication Analysis

Top Keywords

yusho patients
28
yusho
8
serum il-17
8
th17 cells
8
patients dysregulated
8
dysregulated th17
8
th17 cell-mediated
8
cell-mediated immune
8
immune responses
8
secreted th17
8

Similar Publications

Tapinarof is a nonsteroidal, topical, aryl hydrocarbon receptor agonist approved for the treatment of atopic dermatitis (AD) in Japanese patients aged ≥12 years. We evaluated the efficacy and safety of tapinarof in Japanese pediatric patients aged 2 to 11 years with AD in a phase 2, multicenter, randomized, double-blind, vehicle-controlled trial. Eligible patients (N = 121) were randomized 1:1:1 to receive tapinarof cream 0.

View Article and Find Full Text PDF
Article Synopsis
  • Tapinarof cream 1% is a nonsteroidal topical treatment evaluated in two phase 3 trials for Japanese patients aged 12 and older with atopic dermatitis (AD).
  • In trial ZBB4-1, tapinarof showed significantly better outcomes, with 20.24% of patients achieving clear or almost clear skin compared to 2.24% for the vehicle; ZBB4-2 demonstrated ongoing effectiveness over 52 weeks.
  • Most side effects were mild to moderate, and common issues included folliculitis, acne, and headaches, indicating that tapinarof is generally safe for long-term use in treating AD.
View Article and Find Full Text PDF
Article Synopsis
  • - Tapinarof cream (1%) was tested for treating plaque psoriasis in two phase 3 trials involving Japanese patients, showing a significant improvement in psoriasis symptoms compared to a vehicle (inactive treatment).
  • - In the first trial (ZBA4-1), 20.06% of patients using tapinarof achieved high success at week 12 compared to only 2.5% with the vehicle, while in the second trial (ZBA4-2), the treatment success rate increased to 56.3% by week 52.
  • - The treatment was generally safe, with most side effects being mild or moderate, such as folliculitis and contact dermatitis, confirming tapinarof cream's efficacy and safety for
View Article and Find Full Text PDF

Global prevalence of oral pigmentation and its related factors: a systematic review and meta-analysis.

J Stomatol Oral Maxillofac Surg

October 2022

Research Center for Environmental Determinants of Health, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran. Electronic address:

Background: Oral pigmentation is due to the accumulation of one or more pigments in tissues, causing changes in the color of the oral mucosal surfaces. Understanding the exact global prevalence of oral pigmentation and its associated factors helps researchers make the proper interventions at the right time; in this respect, the objective of the present systematic review and meta-analysis was to determine the global prevalence of oral pigmentation and its related factors.

Method: A systematic review and meta- analysis were conducted using the following databases: Magiran, SID, Scopus, Embase, PubMed, Web of Science (WoS), and Google Scholar.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!